Occurrence and persistence of symptoms, diagnoses and prescriptions after community-diagnosed COVID-19: a matched cohort study using the OpenSAFELY platform
Long-COVID symptoms and new prescribing generally reduce over time and are potentially less problematic following less severe illness. Fatigue/cognitive/mobility symptoms persist following COVID-19.
Authors
- Thomas E. Cowling (ORCID: https://orcid.org/0000-0003-1524-4393)
- Kevin Wing (ORCID: https://orcid.org/0000-0003-2335-9641)
- Alex J Walker (ORCID: https://orcid.org/0000-0003-4932-6135)
- Caroline E Morton (ORCID: https://orcid.org/0000-0003-0783-0042)
- Rosalind M. Eggo (ORCID: https://orcid.org/0000-0002-0362-6717)
- Kathryn E. Mansfield (ORCID: https://orcid.org/0000-0002-2551-410X)
- Ruth Costello (ORCID: https://orcid.org/0000-0003-2709-6666)
- Ben Goldacre (ORCID: https://orcid.org/0000-0002-5127-4728)
- OpenSAFELY Collaborative
- Viyaasan Mahalingasivam (ORCID: https://orcid.org/0000-0002-3157-1127)
- Liang-Yu Lin
- The Lh W Ncs Or Convalescence Collaborative
- Stephen JW. Evans
- Ian Douglas
- Peter Inglesby
- Sebastian Bacon
- Amir Mehrkar
- Laurie Tomlinson
Institutions
- National Taipei University of Nursing and Health Science (TW)
- Angkor Hospital for Children (KH)
- London School of Hygiene & Tropical Medicine (GB)
- Public Health Scotland (GB)
- University of Lincoln (GB)
Publication Details
- Journal
- Journal of Epidemiology & Community Health
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1136/jech-2025-225474
- Primary Topic
- Dermatological and COVID-19 studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00